Samsung Biologics เลือกแพลตฟอร์ม Growth Direct® ของ Rapid Micro Biosystems เพื่อทำการทดสอบการควบคุมคุณภาพทางจุลชีววิทยาที่สำคัญโดยอัตโนมัติ
04. Januar 2024 09:18 ET
|
Rapid Micro Biosystems, Inc.
โลเวลล์ แมสซาชูเซตส์ , Jan. 04, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (“บริษัท”)...
Samsung Biologics memilih platform Growth Direct® oleh Rapid Micro Biosystems untuk mengautomasikan ujian kawalan kualiti mikrobiologi kritikal
04. Januar 2024 09:18 ET
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) ("Syarikat"), sebuah syarikat teknologi sains hayat inovatif yang menyediakan penyelesaian automasi...
サムスンバイオロジクス （Samsung Biologics）、重要な微生物の品質管理テスト自動化にラピッド・マイクロ・バイオシステムズ (Rapid Micro Biosystems) のグロースダイレクト (Growth Direct®) プラットフォームを選択
04. Januar 2024 09:18 ET
|
Rapid Micro Biosystems, Inc.
マサチューセッツ州ローウェル発, Jan. 04, 2024 (GLOBE NEWSWIRE) -- ヘルスケア製品の効率的な製造と迅速かつ安全なリリースを促進するミッションクリティカルな自動化ソリューションを提供する革新的なライフサイエンステクノロジー企業であるラピッド・マイクロ・バイオシステムズ (Rapid Micro Biosystems, Inc.) (NASDAQ: RPID)...
Samsung Biologics memilih platform Growth Direct® milik Rapid Micro Biosystems untuk mengotomatiskan pengujian kendali mutu mikrobiologi yang penting
04. Januar 2024 09:18 ET
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (“Perusahaan”), perusahaan teknologi ilmu hayati inovatif yang menyediakan solusi otomatisasi yang...
Samsung Biologics 選擇 Rapid Micro Biosystems 的 Growth Direct® 平台以自動化關鍵微生物品質控制測試
04. Januar 2024 09:18 ET
|
Rapid Micro Biosystems, Inc.
羅威爾，麻薩諸塞州, Jan. 04, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID)（以下簡稱「公司」）是一間創新生命科學技術公司，提供關鍵任務自動化解決方案，以促進醫療保健產品的高效生產和快速、安全發布。該公司今日宣布 Samsung Biologics (KRX: 207940.KS) 選擇了...
Samsung Biologics selects Rapid Micro Biosystems’ Growth Direct® platform to automate critical microbiology quality control testing
04. Januar 2024 07:00 ET
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., Jan. 04, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation...
Rapid Micro Biosystems to Present at 42nd Annual J.P. Morgan Healthcare Conference
03. Januar 2024 07:15 ET
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., Jan. 03, 2024 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation...
Rapid Micro Biosystems to Participate in Upcoming Investor Conferences
07. November 2023 16:15 ET
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., Nov. 07, 2023 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission critical automation...
Rapid Micro Biosystems Reports Third Quarter 2023 Financial Results
03. November 2023 07:00 ET
|
Rapid Micro Biosystems, Inc.
Reports third quarter 2023 total revenue of $6.1 million, representing growth of 30% compared to third quarter 2022 Reaffirms full year 2023 total revenue guidance of at least $22.0 million,...
Rapid Micro Biosystems to Announce Third Quarter 2023 Financial Results on November 3, 2023
19. Oktober 2023 16:15 ET
|
Rapid Micro Biosystems, Inc.
LOWELL, Mass., Oct. 19, 2023 (GLOBE NEWSWIRE) -- Rapid Micro Biosystems, Inc. (Nasdaq: RPID) (the “Company”), an innovative life sciences technology company providing mission-critical automation...